Solventum Co. (NYSE:SOLV) Shares Acquired by Invesco Ltd.

Invesco Ltd. lifted its holdings in shares of Solventum Co. (NYSE:SOLV - Free Report) by 6.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,923,119 shares of the company's stock after acquiring an additional 176,201 shares during the period. Invesco Ltd. owned approximately 1.69% of Solventum worth $193,101,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Modus Advisors LLC purchased a new position in Solventum during the fourth quarter valued at approximately $25,000. Stonebridge Financial Group LLC purchased a new stake in shares of Solventum during the fourth quarter worth $26,000. Crews Bank & Trust acquired a new stake in Solventum in the 4th quarter valued at about $32,000. Synergy Asset Management LLC purchased a new position in Solventum during the fourth quarter worth approximately $35,000. Finally, Spire Wealth Management purchased a new stake in shares of Solventum in the fourth quarter valued at about $37,000.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Bank of America upped their price objective on shares of Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a report on Wednesday, February 26th. Mizuho upped their target price on shares of Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. The Goldman Sachs Group raised their price target on Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research note on Monday, March 3rd. Morgan Stanley upped their target price on shares of Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a report on Wednesday, March 5th. Finally, Piper Sandler lifted their price target on Solventum from $75.00 to $84.00 and gave the stock a "neutral" rating in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $79.86.

Solventum Stock Up 1.8 %

Solventum stock traded up $1.18 during midday trading on Thursday, hitting $66.85. 199,036 shares of the company were exchanged, compared to its average volume of 1,325,226. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $85.92. The company's fifty day moving average price is $73.72 and its 200-day moving average price is $71.64. The company has a market cap of $11.56 billion and a PE ratio of 24.29.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.